419 related articles for article (PubMed ID: 10680439)
1. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
Nenoff P; Oswald U; Haustein UF
Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
Nenoff P; Taneva E; Pfeil B; Oswald U; Haustein UF
Mycoses; 1999 Apr; 42(1-2):55-60. PubMed ID: 10394849
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility testing of fluconazole: evaluation of a multicenter study of the working group "Clinical Mycology" of the German Speaking Mycological Society].
Schmalreck AF
Mycoses; 1996; 39 Suppl 2():1-11. PubMed ID: 9198736
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility testing of yeasts against fluconazole: comparison of the Etest method with microdilution and agar dilution].
Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Vanca E
Mycoses; 1996; 39 Suppl 2():31-8. PubMed ID: 9198742
[TBL] [Abstract][Full Text] [Related]
5. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
[TBL] [Abstract][Full Text] [Related]
6. Testing susceptibility of Candida species to fluconazole and itraconazole using the microdilution assay.
Seibold M; Werner E
Mycoses; 1995; 38(11-12):443-8. PubMed ID: 8720193
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Skrodeniene E; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
[TBL] [Abstract][Full Text] [Related]
8. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
9. [Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest].
Blaschke-Hellmessen R
Mycoses; 1996; 39 Suppl 2():39-43. PubMed ID: 9198743
[TBL] [Abstract][Full Text] [Related]
10. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Yamane N; Igari J
Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
[TBL] [Abstract][Full Text] [Related]
11. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
12. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
Martín-Mazuelos E; Gutiérrez MJ; Aller AI; Bernal S; Martínez MA; Montero O; Quindós G
J Antimicrob Chemother; 1999 Apr; 43(4):477-81. PubMed ID: 10350375
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
Fung-Tomc JC; White TC; Minassian B; Huczko E; Bonner DP
Diagn Microbiol Infect Dis; 1999 Oct; 35(2):163-7. PubMed ID: 10579098
[TBL] [Abstract][Full Text] [Related]
14. Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts.
Sekhon AS; Garg AK; Hamir Z
Mycoses; 1991; 34(7-8):319-22. PubMed ID: 1803235
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazole.
Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Scharr E; Vanca E
Mycoses; 1995; 38(9-10):359-68. PubMed ID: 8569810
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Swinne D; Watelle M; Nolard N
Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
Berenguer J; Fernández-Baca V; Sánchez R; Bouza E
Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):362-5. PubMed ID: 7649205
[TBL] [Abstract][Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Uzun O; Arikan S; Kocagöz S; Sancak B; Unal S
Diagn Microbiol Infect Dis; 2000 Oct; 38(2):101-7. PubMed ID: 11035241
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
